Laila Noor Menon, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 170 Medical Park Rd, Mooresville, NC 28117 Phone: 704-664-9506 |
Dr. Stephen Peter Stowe, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 603 East Center St, Suite A, Mooresville, NC 28115 Phone: 704-663-5090 Fax: 704-663-5502 |
Dr. Michael Whiting Ryan, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 150 Fairview Rd, Suite 120, Mooresville, NC 28117 Phone: 704-377-4009 |
Dr. John H Moore Iii, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 150 Fairview Rd, Suite 120, Mooresville, NC 28117 Phone: 704-377-4009 |
John Carl Clements, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 106 Alexander Bank Dr Ste 200, Mooresville, NC 28117 Phone: 704-660-2622 Fax: 704-660-2633 |
Carl A Foulks Jr., M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 106 Alexander Bank Dr Ste 200, Mooresville, NC 28117 Phone: 704-660-2622 Fax: 704-660-2633 |
News Archive
Hotheaded, impulsive men who shoot first and ask questions later are a staple of Westerns and 1970s cop films, but new research shows there might be truth to the trope.
Bayer HealthCare Pharmaceuticals today announced that XARELTO (rivaroxaban), a novel anti-clotting therapy, achieved improvement in net clinical benefit in a study looking at treatment of patients with deep vein thrombosis. DVT is the formation of a blood clot in a deep vein, usually in the legs, that partially or totally blocks the flow of blood.
Catherine Arnst, writing for Kaiser Health News in collaboration with The Boston Globe, reports: "Dr. Dennis M. Dimitri, a family physician, runs a pretty unusual office. Few appointments are accepted in advance. Instead, patients call in the morning and are assigned a time slot later that day.
Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced financial results for the first quarter ended March 31, 2014.
Authorities in China say a suspected outbreak of the H5N1 bird flu virus has been discovered among ducks in an outlying district of the southern city of Guangzhou.
› Verified 2 days ago